Case Report

Volume: 8 | Issue: 8 | Published: Sep 28, 2024 | Pages: 158 - 160 | DOI: 10.24911/ejmcr.173-1702315757

Etanercept induced erectile dysfunction


Authors: Ozge Sonmez , Serdal Ugurlu


Article Info

Authors

Ozge Sonmez

Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul

Serdal Ugurlu

Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul

Publication History

Received: December 11, 2023

Revised: May 09, 2024

Accepted: May 12, 2024

Published: September 28, 2024


Abstract


Background: Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial spine. Etanercept is a Tumor necrosis factor-alpha inhibitor (anti-TNF) that is widely used in the treatment of AS. The most common side effects of etanercept are infection, rash, and injection site reaction. Here, we reported an adverse event probably associated with etanercept. Case Presentation: A 30-year-old male patient with AS initiated etanercept due to uncontrolled back pain despite adequate doses of non-steroidal anti-inflammatory drugs. He developed erectile dysfunction (ED) within 1 month of etanercept treatment. ED disappeared after switching to secukinumab. Conclusion: There is limited data on the potential effects of anti-TNF on sexual function. ED might be a rare side effect of etanercept that resolves upon discontinuation of the drug. Secukinumab might be considered as an option in case of etanercept induced ED. Even though ED is not a life-threatening side effect, switching medications could significantly improve patients' quality of life.

Keywords: Etanercept, tumor necrosis factor-alpha inhibitor, erectile dysfunction, ankylosing spondylitis, case report, green


Pubmed Style

Ozge Sonmez, Serdal Ugurlu. Etanercept induced erectile dysfunction. EJMCR. 2024; 28 (September 2024): 158-160. doi:10.24911/ejmcr.173-1702315757

Web Style

Ozge Sonmez, Serdal Ugurlu. Etanercept induced erectile dysfunction. https://ejmcr.com/articles/1228 [Access: November 06, 2024]. doi:10.24911/ejmcr.173-1702315757

AMA (American Medical Association) Style

Ozge Sonmez, Serdal Ugurlu. Etanercept induced erectile dysfunction. EJMCR. 2024; 28 (September 2024): 158-160. doi:10.24911/ejmcr.173-1702315757

Vancouver/ICMJE Style

Ozge Sonmez, Serdal Ugurlu. Etanercept induced erectile dysfunction. EJMCR. (2024), [cited November 06, 2024]; 28 (September 2024): 158-160. doi:10.24911/ejmcr.173-1702315757

Harvard Style

Ozge Sonmez, Serdal Ugurlu (2024) Etanercept induced erectile dysfunction. EJMCR, 28 (September 2024): 158-160. doi:10.24911/ejmcr.173-1702315757

Chicago Style

Ozge Sonmez, Serdal Ugurlu. "Etanercept induced erectile dysfunction." 28 (2024), 158-160. doi:10.24911/ejmcr.173-1702315757

MLA (The Modern Language Association) Style

Ozge Sonmez, Serdal Ugurlu. "Etanercept induced erectile dysfunction." 28.September 2024 (2024), 158-160. Print. doi:10.24911/ejmcr.173-1702315757

APA (American Psychological Association) Style

Ozge Sonmez, Serdal Ugurlu (2024) Etanercept induced erectile dysfunction. , 28 (September 2024), 158-160. doi:10.24911/ejmcr.173-1702315757